Reported 1 day ago
DexCom Inc. (NASDAQ:DXCM) experienced a significant 13.9% increase in its stock price last week, closing at $81.62, following a reaffirmation of its revenue guidance and a strong sales report for Q1. The American healthcare company aims for a 14% growth in revenue for 2025, backed by the anticipated launch of its Dexcom G7 system, despite a decline in net income. Amid a generally optimistic market, DexCom ranked 10th among firms that posted considerable gains last week.
Source: YAHOO